Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Study: Suppressing Key Protein May Unlock Immunotherapy for Glioblastoma

Glioblastoma is one of the toughest cancers to treat, but a new study suggests that suppressing a protein (ZNF638) triggers an antiviral immune response, making immune checkpoint inhibitors more effective. The discovery also identifies ZNF638 as a biomarker that could help personalize immunotherapy.

March 17, 2025


March 17 2025

March 16 2025

March 15 2025

March 14 2025

March 13 2025

March 12 2025

March 11 2025

March 10 2025

March 9 2025

March 8 2025

March 7 2025

March 6 2025

March 5 2025

March 4 2025